Li, Rui
Tang, Hao
Burns, Jeremy C.
Hopkins, Brian T.
Le Coz, Carole
Zhang, Bo
de Barcelos, Isabella Peixoto
Romberg, Neil
Goldstein, Amy C.
Banwell, Brenda L.
Luning Prak, Eline T.
Mingueneau, Michael
Bar-Or, Amit http://orcid.org/0000-0001-7179-0335
Funding for this research was provided by:
the Melissa and Paul Anderson Gift Fund at the University of Pennsylvania
Center for Mitochondrial and Epigenomic Medicine
Biogen
Article History
Received: 21 December 2021
Revised: 5 March 2022
Accepted: 6 March 2022
First Online: 18 March 2022
Declarations
:
: H.T, B.T.H and M.M are current employees of Biogen, MA. J.B was a former employee of Biogen and current employee of Abata Therapeutics. N.R receives salary support from the Jeffrey Modell Foundation. Amit Bar-Or has participated as a speaker in meetings sponsored by and received consulting fees and/or grant support from: Accure, Atara Biotherapeutics, Biogen, BMS/Celgene/Receptos, GlaxoSmithKline, Gossamer, Janssen/Actelion, Medimmune, Merck/EMD Serono, Novartis, Roche/Genentech, Sanofi-Genzyme.